Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.

BACKGROUND The possibility that substantial heterogeneity in metabolic abnormalities exists in moderately obese individuals has not been emphasized in studies of the effect of obesity on morbidity and mortality. We tested the hypothesis that risk factors for type 2 diabetes mellitus and cardiovascular disease vary dramatically in moderately obese individuals as a function of differences in a specific measure of insulin sensitivity. METHODS Participants included 211 apparently healthy, obese (body mass index [calculated as weight in kilograms divided by height in meters squared], 30.0-34.9) volunteers for weight loss studies. Main outcome measures included insulin-mediated glucose uptake as quantified by the insulin suppression test and metabolic variables known to increase the risk for type 2 diabetes and cardiovascular disease. RESULTS Insulin sensitivity varied 6-fold. When compared with the most insulin-sensitive third, the most insulin-resistant third of the population had significantly higher (P<.001) systolic and diastolic blood pressure (139 +/- 20 vs 123 +/- 18 mm Hg, and 83 +/- 3 vs 75 +/- 10 mm Hg, respectively), higher fasting and 2-hour oral glucose load concentrations (103 +/- 11 vs 95 +/- 11 mg/dL [5.7 +/- 0.6 vs 5.3 +/- 0.6 mmol/L], and 139 +/- 30 vs 104 +/- 19 mg/dL [7.7 +/- 1.7 vs 5.8 +/- 1.1 mmol/L], respectively), higher plasma triglyceride concentrations (198 +/- 105 vs 114 +/- 51 mg/dL [2.2 +/- 1.2 vs 1.3 +/- 0.6 mmol/L]), lower plasma high-density lipoprotein cholesterol concentrations (41 +/- 9 vs 50 +/- 13 mg/dL [1.1 +/- 0.2 vs 1.3 +/- 0.3 mmol/L]), and more prevalent impaired glucose tolerance (47% vs 2%). CONCLUSIONS The magnitude of risk factors for type 2 diabetes and cardiovascular disease varies markedly in moderately obese individuals as a function of differences in degree of insulin sensitivity. Because not all moderately obese individuals are at similar risk for developing type 2 diabetes and cardiovascular disease, intensive therapeutic interventions should be addressed to the insulin-resistant subset of this population.

[1]  G. Reaven,et al.  Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test , 1994, Diabetologia.

[2]  M. Gail,et al.  Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence: A Randomized Controlled Trial , 2005, Gynecologic oncology.

[3]  G. Reaven.  The insulin resistance syndrome , 2003, Current atherosclerosis reports.

[4]  G. Reaven,et al.  Why the plasma TG/HDL-C concentration ratio does not predict insulin resistance in African Americans. , 2006, Archives of internal medicine.

[5]  T. McLaughlin,et al.  Effects of moderate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulin-resistant adults. , 2006, The American journal of clinical nutrition.

[6]  T. McLaughlin,et al.  Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women. , 2001, Metabolism: clinical and experimental.

[7]  D Spiegelman,et al.  Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. , 1995, American journal of epidemiology.

[8]  G. Reaven,et al.  Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. , 1970, The Journal of clinical investigation.

[9]  V. Montori,et al.  Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies , 2006, The Lancet.

[10]  M. Thun,et al.  Body-mass index and mortality in a prospective cohort of U.S. adults. , 1999, The New England journal of medicine.

[11]  G. Reaven,et al.  Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. , 2000, Diabetes care.

[12]  C. Lamendola,et al.  Differentiation Between Obesity and Insulin Resistance in the Association With C-Reactive Protein , 2002, Circulation.

[13]  M. Thun,et al.  Body-Mass Index and Mortality in a Prospective Cohort of US Adults , 2000 .

[14]  M. Saad,et al.  Insulin resistance in essential hypertension. , 1990, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[15]  K. Flegal,et al.  Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. , 2004, JAMA.

[16]  J. Shaw,et al.  Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.

[17]  G. Reaven,et al.  Insulin resistance as a predictor of age-related diseases. , 2001, The Journal of clinical endocrinology and metabolism.

[18]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[19]  J. Manson,et al.  Annual deaths attributable to obesity in the United States. , 1999, JAMA.

[20]  G. Reaven.  Importance of Identifying the Overweight Patient Who Will Benefit the Most by Losing Weight , 2003, Annals of Internal Medicine.

[21]  A. Krolewski,et al.  Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. , 1990, Annals of internal medicine.

[22]  G. Reaven,et al.  Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. , 1998, The Journal of clinical endocrinology and metabolism.

[23]  J. Manson,et al.  Adiposity as compared with physical activity in predicting mortality among women. , 2005, The New England journal of medicine.

[24]  G. Reaven,et al.  Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. , 2003, The Journal of clinical endocrinology and metabolism.

[25]  E. Gregg,et al.  Secular Trends in Cardiovascular Disease Risk Factors According to Body Mass Index in US Adults , 2005 .

[26]  K. M. West,et al.  Influence of Nutritional Factors on Prevalence of Diabetes , 1971, Diabetes.

[27]  E. Ravussin,et al.  Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. , 1993, The New England journal of medicine.

[28]  G. Dagenais,et al.  Hyperinsulinemia as an independent risk factor for ischemic heart disease. , 1996, The New England journal of medicine.

[29]  Tracey McLaughlin,et al.  Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant , 2003, Annals of Internal Medicine.

[30]  J. Gerberding,et al.  Actual causes of death in the United States, 2000. , 2004, JAMA.

[31]  G. O. Lignac.  [Actual causes of death]. , 1951, Nederlands tijdschrift voor geneeskunde.

[32]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[33]  G. Reaven,et al.  Assessment of Insulin Resistance with the Insulin Suppression Test and the Euglycemic Clamp , 1981, Diabetes.

[34]  McGinnis Jm,et al.  Actual causes of death in the United States. , 1993 .

[35]  Tracey McLaughlin,et al.  Relationship between obesity, insulin resistance, and coronary heart disease risk. , 2002, Journal of the American College of Cardiology.

[36]  P. Tsao,et al.  Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss. , 2006, The Journal of clinical endocrinology and metabolism.

[37]  J. Manson,et al.  The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians. , 2004, Archives of internal medicine.

[38]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.

[39]  T. McLaughlin,et al.  Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women. , 1999, The Journal of clinical endocrinology and metabolism.

[40]  R. Havlik,et al.  Weight and hypertension. , 1983, Annals of internal medicine.

[41]  D. Allison,et al.  Years of life lost due to obesity. , 2003, JAMA.